05:03 PM EST, 12/06/2024 (MT Newswires) -- NeuroSense Therapeutics ( NRSN ) late Friday disclosed plans by one of its larger institutional investors to sell a portion of its stake in the biotechnology company from time to time.

The company filed a preliminary prospectus Friday for Rimon Gold Assets to sell up to 11 million of its NeuroSense ordinary shares, including 4.4 million share it would receive by exercising warrants.

NeuroSense will not receive any proceeds from the secondary sale.